ELHAM JAFROODI: Open Payments
NPI 1033473533 · STANFORD, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$674 in 11 payments from 6 companies in 2025. Trend: 2023 $9,022 · 2024 $1,829 · 2025 $674
Food & beverage: $674
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $176 |
| Edwards Lifesciences Corporation | 1 | $137 |
| Sumitomo Pharma America, Inc. | 2 | $119 |
| ARGENX US, INC. | 1 | $115 |
| Amgen Inc. | 1 | $85 |
| Daiichi Sankyo Inc. | 2 | $43 |
Products named: SAPIEN 3 Ultra RESILIA, ORGOVYX, VYVGART, KRYSTEXXA, ENHERTU.
Industry payments across CA — which companies pay providers there.
